BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 27222255)

  • 1. Downregulation of lncRNA CASC2 by microRNA-21 increases the proliferation and migration of renal cell carcinoma cells.
    Cao Y; Xu R; Xu X; Zhou Y; Cui L; He X
    Mol Med Rep; 2016 Jul; 14(1):1019-25. PubMed ID: 27222255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA‑21 contributes to renal cell carcinoma cell invasiveness and angiogenesis via the PDCD4/c‑Jun (AP‑1) signalling pathway.
    Fan B; Jin Y; Zhang H; Zhao R; Sun M; Sun M; Yuan X; Wang W; Wang X; Chen Z; Liu W; Yu N; Wang Q; Liu T; Li X
    Int J Oncol; 2020 Jan; 56(1):178-192. PubMed ID: 31789394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA CASC2 suppresses malignancy in human gliomas by miR-21.
    Wang P; Liu YH; Yao YL; Li Z; Li ZQ; Ma J; Xue YX
    Cell Signal; 2015 Feb; 27(2):275-82. PubMed ID: 25446261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non‑coding RNA CASC2 inhibits progression and predicts favorable prognosis in epithelial ovarian cancer.
    Xue Z; Zhu X; Teng Y
    Mol Med Rep; 2018 Dec; 18(6):5173-5181. PubMed ID: 30320385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of the long noncoding RNA TUG1 inhibits the proliferation, migration, invasion and promotes apoptosis of renal cell carcinoma.
    Zhang M; Lu W; Huang Y; Shi J; Wu X; Zhang X; Jiang R; Cai Z; Wu S
    J Mol Histol; 2016 Aug; 47(4):421-8. PubMed ID: 27323757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. lncRNA CASC2/miR‑18a‑5p axis regulates the malignant potential of nasopharyngeal carcinoma by targeting RBBP8.
    Miao WJ; Yuan DJ; Zhang GZ; Liu Q; Ma HM; Jin QQ
    Oncol Rep; 2019 Mar; 41(3):1797-1806. PubMed ID: 30569153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Berberine Promotes Apoptosis of Colorectal Cancer via Regulation of the Long Non-Coding RNA (lncRNA) Cancer Susceptibility Candidate 2 (CASC2)/AU-Binding Factor 1 (AUF1)/B-Cell CLL/Lymphoma 2 (Bcl-2) Axis.
    Dai W; Mu L; Cui Y; Li Y; Chen P; Xie H; Wang X
    Med Sci Monit; 2019 Jan; 25():730-738. PubMed ID: 30681073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA‑24‑2 is associated with cell proliferation, invasion, migration and apoptosis in renal cell carcinoma.
    Jin L; Li Y; Nie L; He T; Hu J; Liu J; Chen M; Shi M; Jiang Z; Gui Y; Yang S; Lai Y
    Mol Med Rep; 2017 Dec; 16(6):9157-9164. PubMed ID: 28990105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor suppressive microRNA‑138 contributes to cell migration and invasion through its targeting of vimentin in renal cell carcinoma.
    Yamasaki T; Seki N; Yamada Y; Yoshino H; Hidaka H; Chiyomaru T; Nohata N; Kinoshita T; Nakagawa M; Enokida H
    Int J Oncol; 2012 Sep; 41(3):805-17. PubMed ID: 22766839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA-133b downregulation and inhibition of cell proliferation, migration and invasion by targeting matrix metallopeptidase-9 in renal cell carcinoma.
    Wu D; Pan H; Zhou Y; Zhou J; Fan Y; Qu P
    Mol Med Rep; 2014 Jun; 9(6):2491-8. PubMed ID: 24714873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. lncRNA small nucleolar RNA host gene 12 promotes renal cell carcinoma progression by modulating the miR‑200c‑5p/collagen type XI α1 chain pathway.
    Xu C; Liang H; Zhou J; Wang Y; Liu S; Wang X; Su L; Kang X
    Mol Med Rep; 2020 Nov; 22(5):3677-3686. PubMed ID: 32901847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of long non-coding RNA differentiation antagonizing non-protein coding RNA inhibits the proliferation, migration and invasion and promotes apoptosis of renal cell carcinoma.
    Jin L; Fu H; Quan J; Pan X; He T; Hu J; Li Y; Li H; Yang Y; Ye J; Zhang F; Ni L; Yang S; Lai Y
    Mol Med Rep; 2017 Oct; 16(4):4463-4468. PubMed ID: 28765964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA TUG1 promotes cell proliferation and migration of renal cell carcinoma via regulation of YAP.
    Liu S; Yang Y; Wang W; Pan X
    J Cell Biochem; 2018 Dec; 119(12):9694-9706. PubMed ID: 30132963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-20b-5p functions as a tumor suppressor in renal cell carcinoma by regulating cellular proliferation, migration and apoptosis.
    Li Y; Chen D; Jin L; Liu J; Su Z; Li Y; Gui Y; Lai Y
    Mol Med Rep; 2016 Feb; 13(2):1895-901. PubMed ID: 26708577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA CASC2 expression is down- regulated in papillary thyroid cancer and promotes cell invasion by affecting EMT pathway.
    Zhou T; Zhong M; Zhang S; Wang Z; Xie R; Xiong C; Lv Y; Chen W; Yu J
    Cancer Biomark; 2018; 23(2):185-191. PubMed ID: 30175973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor suppressive miR-196a is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma.
    Li Y; Jin L; Chen D; Liu J; Su Z; Yang S; Gui Y; Mao X; Nie G; Lai Y
    Mol Med Rep; 2016 Jul; 14(1):560-6. PubMed ID: 27175581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR‑539 suppresses proliferation and induces apoptosis in renal cell carcinoma by targeting high mobility group A2.
    Ye ZH; Gui DW
    Mol Med Rep; 2018 Apr; 17(4):5611-5618. PubMed ID: 29436648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Non-Coding RNA DUXAP8 Enhances Renal Cell Carcinoma Progression via Downregulating miR-126.
    Huang T; Wang X; Yang X; Ji J; Wang Q; Yue X; Dong Z
    Med Sci Monit; 2018 Oct; 24():7340-7347. PubMed ID: 30317248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-22 is downregulated in clear cell renal cell carcinoma, and inhibits cell growth, migration and invasion by targeting PTEN.
    Fan W; Huang J; Xiao H; Liang Z
    Mol Med Rep; 2016 Jun; 13(6):4800-6. PubMed ID: 27082730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-suppressive microRNA-1291 directly regulates glucose transporter 1 in renal cell carcinoma.
    Yamasaki T; Seki N; Yoshino H; Itesako T; Yamada Y; Tatarano S; Hidaka H; Yonezawa T; Nakagawa M; Enokida H
    Cancer Sci; 2013 Nov; 104(11):1411-9. PubMed ID: 23889809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.